Of these, MiR-144, the human equivalent of which was up-regulated in FD patients (Puthanmadhom Narayanan et al., 2021a,b), inhibited the expression of ZO1 and OCLN in a rat model of IBS (Hou et al., 2017). The gene discussed is TJP1; the disease is Fabry disease.